Вы находитесь на странице: 1из 46

The American Journal of Clinical Nutrition

Skip to main page content

HOME

CURRENT ISSUE

EMAIL ALERTS

ARCHIVES

SUBSCRIPTIONS

SEARCH FOR ARTICLES

CUSTOM PUBLICATION FAQ

ASN

Search AJCN

Submit

Advanced Search

2008 American Society for Clinical Nutrition

Vitamin D deficiency: a worldwide problem


with health consequences1,2,3,4
1. Michael F Holick and
2. Tai C Chen
+ Author Affiliations

1.

From the Department of Medicine; Section of Endocrinology, Nutrition, and Diabetes;


Vitamin D, Skin and Bone Research Laboratory; Boston University Medical Center,
Boston, MA

Next Section

Abstract
Vitamin D deficiency is now recognized as a pandemic. The major cause of vitamin D deficiency
is the lack of appreciation that sun exposure in moderation is the major source of vitamin D for
most humans. Very few foods naturally contain vitamin D, and foods that are fortified with
vitamin D are often inadequate to satisfy either a child's or an adult's vitamin D requirement.
Vitamin D deficiency causes rickets in children and will precipitate and exacerbate osteopenia,
osteoporosis, and fractures in adults. Vitamin D deficiency has been associated with increased
risk of common cancers, autoimmune diseases, hypertension, and infectious diseases. A
circulating level of 25-hydroxyvitamin D of >75 nmol/L, or 30 ng/mL, is required to maximize
vitamin D's beneficial effects for health. In the absence of adequate sun exposure, at least 800
1000 IU vitamin D3/d may be needed to achieve this in children and adults. Vitamin D2 may be
equally effective for maintaining circulating concentrations of 25-hydroxyvitamin D when given
in physiologic concentrations.
Previous SectionNext Section

HISTORICAL PERSPECTIVE
Some of the earliest phytoplankton life forms on earth that have existed unchanged in the
Atlantic ocean for >750 y can make vitamin D when exposed to sunlight (1, 2). Most vertebrates,
including amphibians, reptiles, birds, and lower primates, depend on sun exposure for their
vitamin D requirement (2). The lack of sunlight and its association with the devastating bonedeforming disease rickets in children was first recognized by Sniadecki in 1822 (3). One hundred
years would pass before it was observed that exposure to ultraviolet B radiation (UVB; 290315
nm) from a mercury arc lamp or sunlight prevented and treated rickets (4). In the early 1930s, the
US government set up an agency to provide recommendations to parents about the beneficial
effect of sensible exposure to sunlight for the prevention of rickets (4-6).
The fortification of milk in the 1930s with 100 IU vitamin D2 per 8 ounces was effective in
eradicating rickets in the United States and Europe. The unfortunate outbreak of hypercalcemia
in the 1950s in Great Britain was blamed on the overfortification of milk with vitamin D, even
though there was little evidence for this (7). Because milk was scarce at the end of the war, many
local stores that sold milk would add vitamin D to it if it was not purchased by the expiration
date. This was thought to extend the shelf-life of the vitamin Dfortified milk. This rise in the
incidence of hypercalcemia in infants in the 1950s resulted in Europe forbidding the fortification
of dairy products with vitamin D. Only recently have Finland and Sweden begun fortifying milk
with vitamin D.

Previous SectionNext Section

SOURCES OF VITAMIN D
The major source of vitamin D for most humans is exposure to sunlight (1, 2, 4-6). As shown in
Figure 1, seasonal variation is found in the major circulating form of vitamin D, 25hydroxyvitamin D [25(OH)D] (8). Few foods naturally contain vitamin D, including oily fish
such as salmon, mackerel, and herring and oils from fish, including cod liver oil. We recently
conducted a study and observed that wild-caught salmon had on average 5001000 IU vitamin D
in 100 g (3.5 ounces), whereas farmed salmon contained 100250 IU vitamin D per 100-g
serving (9). The most likely reason is that vitamin D is plentiful in the food chain but is not
plentiful in the pelleted diet fed to farmed salmon. In the United States, milk, some juice
products, some breads, yogurts, and cheeses are fortified with vitamin D. Multivitamins that
contain 400 IU vitamin D and supplements containing vitamin D only are now available in
various amounts including 400, 1000, 2000, 4000, 5000 and 50 000 IU vitamin D3. The
pharmaceutical form of vitamin D in the United States is vitamin D2 and is available as 50 000
IU vitamin D2 in a capsule or 8000 IU vitamin D2/mL (4, 10). In Canada, Europe, Japan, and
India, vitamin D3 is available as a pharmaceutical.

View larger version:

In this page

In a new window

Download as PowerPoint Slide

FIGURE 1.
A: Relation between hours of sunshine and serum 25-hydroxyvitamin D [25(OH)D]
concentrations. , hours of sunshine; , 25(OH)D. B: Seasonal fluctuation in serum 25(OH)D
according to frequency of sun exposure. , regular sun exposure; , occasional sun exposure; ,
avoiding direct sun exposure. Adapted from reference 8.
Previous SectionNext Section

CONSEQUENCES OF VITAMIN D DEFICIENCY ON


THE MUSCULOSKELETAL SYSTEM
Much debate has taken place over the definition of vitamin D deficiency. Most agree that a
25(OH)D concentration <50 nmol/L, or 20 ng/mL, is an indication of vitamin D deficiency,
whereas a 25(OH)D concentration of 5174 nmol/L, or 2129 ng/mL, is considered to indicate
insufficiency; concentrations >30 ng/mL are considered to be sufficient (10-15; Figure 2) This
is based on the observation that intestinal calcium absorption is maximized above 80 nmol/L, or
32 ng/mL, in postmenopausal women (16) and that parathyroid hormone (PTH) concentrations
in adults continue to decline and reach their nadir at 75100 nmol/L, or 3040 ng/mL (11, 14,
15). It has been assumed that children have the same requirement as adults; however, no
comparable studies have been carried out on intestinal calcium transport or PTH levels in
children. Vitamin D intoxication typically does not occur until 25(OH)D concentrations are >375
nmol/L, or 150 ng/mL (10, 16, 17).

View larger version:

In this page

In a new window

Download as PowerPoint Slide

FIGURE 2.
Schematic representation of the synthesis and metabolism of vitamin D for regulating calcium,
phosphorus, and bone metabolism. During exposure to sunlight, 7-dehydrocholesterol (7-DHC)
in the skin is converted to previtamin D3 (preD3) and then by a heat-dependent process to vitamin
D3. Vitamin D (D represents D2 or D3) made in the skin or ingested in the diet is converted by the
vitamin D-25-hydroxylase (25-OHase) to 25-hydroxyvitamin D [25(OH)D]. 25(OH)D is
converted in the kidneys by the 25-hydroxyvitamin D-1-hydroxylase (1-OHase) to its
biologically active form 1,25-dihydroxyvitamin D [1,25(OH)2D]. 1,25(OH)2D increases the
expression of the 25-hydroxyvitamin D-24-hydroxylase (24-OHase) to catabolize 1,25(OH)2D
and 25(OH)D to the water-soluble biologically inactive calcitroic acid. 1,25(OH)2D enhances

intestinal calcium absorption in the small intestine. 1,25(OH)2D is recognized by its receptor in
osteoblasts, causing an increase in the expression of receptor activator of NFB ligand
(RANKL). CaBP, calcium binding protein; ECaC, epithelial channel calcium; FGF23, fibroblast
growth factor 23; OJ, orange juice; Pi, inorganic phosphate; PTH, parathyroid hormone; UVB,
ultraviolet B radiation.
Vitamin D deficiency in children will cause growth retardation (5, 18) and classic signs and
symptoms of rickets (4-6, 18). In adults, vitamin D deficiency will precipitate and exacerbate
both osteopenia and osteoporosis and increase the risk of fracture (10, 11, 19, 20).
Muscle weakness has long been associated with vitamin D deficiency. A vitamin D receptor is
present in skeletal muscle (21), and vitamin D deficiency has been associated with proximal
muscle weakness, increase in body sway, and an increased risk of falling (22-24).
Vitamin D deficiency in adults can also cause a skeletal mineralization defect. The unmineralized
osteoid provides little structural support for the periosteal covering. As a result, patients with
osteomalacia often complain of isolated or global bone discomfort along with aches and pains in
their joints and muscles (25-27). These patients may be misdiagnosed with fibromyalgia,
dysthymia, degenerative joint disease, arthritis, chronic fatigue syndrome, and other diseases (10,
25, 28).
Previous SectionNext Section

CAUSES OF VITAMIN D DEFICIENCY


The major source of vitamin D for humans is exposure to sunlight (4, 8, 10). Anything that
diminishes the transmission of solar UVB radiation to the earth's surface or anything that
interferes with the penetration of UVB radiation into the skin will affect the cutaneous synthesis
of vitamin D3 (2, 9; Figure 3) Melanin is extremely efficient in absorbing UVB radiation, and,
thus, increased skin pigmentation markedly reduces vitamin D3 synthesis (29). Similarly, a
sunscreen with a sun protection of 15 absorbs 99% of the incident UVB radiation, and, thus,
when topically applied properly will decrease the synthesis of vitamin D3 in the skin by 99%
(30). African Americans with very dark skin have an SPF of 15, and, thus, their ability to make
vitamin D in their skin is reduced by as much as 99% (9, 29). This along with decreased milk
intake are the explanations for why most African Americans who live in a temperate climate are
vitamin D deficient, whereas Africans living near the equator where vitamin D3 synthesis is more
efficient because of the higher flux of UVB photons are not (31, 32).

View larger version:

In this page

In a new window

Download as PowerPoint Slide

FIGURE 3.
A schematic representation of the major causes of vitamin D deficiency and potential health
consequences. AODM, adult onset diabetes mellitus; CHD, coronary heart disease; FEV1, forced
expiratory volume in 1 s; HAART, highly active antiretroviral therapy; HBP, high blood
pressure; MS, multiple sclerosis; RA, rheumatoid arthritis; TB, tuberculosis; URI, urinary tract
infection.
The angle at which the sun reaches the earth has a dramatic effect on the number of UVB
photons that reach the earth's surface (2, 31). This is why when the zenith angle is increased
during the wintertime and in the early morning and late afternoon, little if any vitamin D3
synthesis occurs (2, 31). The practice of purdah, whereby all skin is covered and prevented from
being exposed to sunlight places those who practice it at high risk of vitamin D deficiency and
explains why in the sunniest areas of the world vitamin D deficiency is very common in both
children and adults (33, 34). No one is immune from vitamin D deficiency. This includes both
children and adults living in the United States, Europe, Middle East, India, Australia, and Asia.
These studies suggest that upwards of 3050% of children and adults are at risk of vitamin D
deficiency (33-42).
Aging is associated with decreased concentrations of 7-dehydrocholesterol, the precursor of
vitamin D3 in the skin. A 70-y-old has 25% of the 7-dehydrocholesterol that a young adult does
and thus has a 75% reduced capacity to make vitamin D3 in the skin (43). Because vitamin D is
fat soluble, it is readily taken up by fat cells. Obesity is associated with vitamin D deficiency, and
it is believed to be due to the sequestration of vitamin D by the large body fat pool (44).
Medications including antiseizure medications and glucocorticoids and fat malabsorption are
also common causes of deficiency (45; Figure 3).
Previous SectionNext Section

NONSKELETAL CONSEQUENCES OF VITAMIN D


DEFICIENCY
More than 80 y ago, it was reported that living at higher latitudes in the United States correlated
with an increased risk of dying of common cancers (46). In the 1980s and 1990s, several
observations suggested that living at higher latitudes increased the risk of developing and dying
of colon, prostate, breast, and several other cancers (47-52). Because living at higher latitudes
diminishes vitamin D3 production, it was suggested that an association may exist between

vitamin D deficiency and cancer mortality. Both men and women exposed to the most sunlight
throughout their lives were less likely to die of cancer (50-54). Several retrospective and
prospective studies that evaluated circulating concentrations of 25(OH)D support the concept
that vitamin D deficiency increases the risk of developing and dying from cancer (52, 53). It has
been suggested that adults with 25(OH)D of <50 nmol/L who were then followed for up to 19 y
had a 3050% increased risk of developing colorectal, breast, prostate, and many other cancers
(50, 52, 54, 55). A meta-analysis showed that increasing intake of vitamin D to 1000 IU vitamin
D3/d would be associated with a decreased risk of colorectal and breast cancer of as much as
50% (53). Men who ingested >400 IU vitamin D/d had a markedly reduced risk of developing
several cancers, including those of the pancreas and esophagus and non-Hodgkin lymphoma
(52). Lappe et al (56) reported that postmenopausal women who received 1100 IU vitamin D3
and 1000 mg Ca daily for 4 y reduced their risk of developing cancer by 60%.
Living at higher latitudes is associated with an increased risk of type 1 diabetes (57), multiple
sclerosis (58, 59), and hypertension (60). Children who received 2000 IU vitamin D/d during the
first year of life and who were followed for 31 y were found to have a reduced risk of developing
type 1 diabetes by 78% compared with children who were not supplemented with vitamin D
(61). Women who received >400 IU vitamin D/d were found to have a >40% reduced risk of
developing multiple sclerosis (62) and rheumatoid arthritis (63). Hypertensive patients who were
exposed to a tanning bed raised their blood concentrations of 25(OH)D by >180% in 3 mo and
became normotensive (64). Patients who live at higher latitudes and are at risk of vitamin D
deficiency are also more prone to developing schizophrenia (65), and vitamin D deficiency has
been associated with depression (66). Vitamin D deficiency in pregnancy has also been
associated with an increased risk of preeclampsia (67).
African Americans are at higher risk of developing and having more severe cases of tuberculosis.
It has been known for >100 y that exposure to sunlight helped in the treatment of tuberculosis
(68). Liu et al (69) reported that the likely mechanism is that when a macrophage is infected with
tuberculosis, it stimulates the cell to increase the production of 1,25-dihydroxyvitamin D3
[1,25(OH)2D3] and increase the expression of the vitamin D receptor. In combination, they
enhanced the gene expression of the bacteriocidal protein cathelicidin, which is known to kill
tuberculosis and other infective agents (Figure 4).

View larger version:

In this page

In a new window

Download as PowerPoint Slide

FIGURE 4.
Metabolism of 25-hydroxyvitamin D [25(OH)D] to 1,25 dihydroxyvitamin D [1,25(OH)2D] for
nonskeletal functions. When a monocyte or macrophage is stimulated through its toll-like
receptor 2/1 (TLR2/1) by an infective agent such as Mycobacterium tuberculosis (TB) or its
lipopolysaccharide (LPS), the signal up-regulates the expression of vitamin D receptor (VDR)
and the 25-hydroxyvitamin D-1-hydroxylase (1-OHase). 1,25(OH)2D increases the expression of
cathelicidin (CD). When 25(OH)D concentrations are 30 ng/mL, the risk of many common
cancers is reduced. It is believed that the local production of 1,25(OH)2D regulates genes that
control proliferation and apoptosis. AB, B-lymphocytes; AT, T-lymphocytes; BP, blood pressure;
BS, blood sugar; 24-OHase, 25-hydroxyvitaminD-24-hydroxylase; PTH, parathyroid hormone.
Previous SectionNext Section

MECHANISMS OF ACTION OF VITAMIN D


Vitamin D is metabolized in the liver to 25(OH)D and then in the kidneys to 1,25(OH)2D (70, 71;
Figure 2). It is also recognized that many other tissues in the body, including macrophages,
brain, colon, prostate, breast, and others, have the enzymatic machinery to locally produce
1,25(OH)2D (72-76; Figure 4). 1,25(OH)2D produced by the kidneys enters the circulation and
travels to its major target tissues the intestine and bone, where it interacts with its vitamin D
receptor to enhance intestinal calcium absorption and mobilize osteoclastic activity (70; Figure
3).
The local production of 1,25(OH)2D in non-calcium-regulating tissues such as the colon,
prostate, and breast is thought to be for the purpose of regulating up to 200 genes, which helps to
control cell growth and cellular differentiation and may be responsible for decreasing the risk of
the cells being transformed into a malignant state (77). 1,25(OH)2D3 has been shown to inhibit
cancer cell growth, induce cancer cell maturation, induce apoptosis, and decrease angiogenesis
(77, 78; Figure 4). 1,25(OH)2D inhibits renin production in the kidney (79) and has a
immunomodulatory activity on monocytes and activated T and B lymphocytes (80-82; Figure
4).
Previous SectionNext Section

PREVENTION AND TREATMENT OF VITAMIN D


DEFICIENCY

The Institute of Medicine recommended that all children (also endorsed by the American
Academy of Pediatrics) and adults up to the age of 50 y require 200 IU vitamin D/d and adults
aged 5170 and 71 y need 400 and 600 IU vitamin D/d (83). The National Osteoporosis
Foundation recently recommended that all postmenopausal women take 8001000 IU vitamin
D/d (84). Cheng et al (85) reported an association of low 25(OH)D concentrations with elevated
serum PTH concentrations and low cortical bone density in early pubertal and prepubertal
Finnish girls. This confirmed the earlier observations of Outila et al (86), who noted elevated
PTH concentrations and lower forearm bone density and vitamin D deficiency in the winter in
adolescent females, and Guillemant et al (87), who observed seasonal variation in PTH
concentrations in growing male adolescents. When 171 prepubertal girls were given 400 IU
vitamin D2/d from October to February and 500 mg Ca supplementation, their serum 25(OH)D
concentrations did not change. When these girls received 800 IU vitamin D2/d, their blood
concentrations rose during the winter but did not reach concentrations observed during the
summer (88). Thus, on the basis of these and other observations, many experts now agree that in
the absence of adequate sun exposure, 8001000 IU vitamin D/d is needed for children of all
ages and adults of all ages (84, 88-91), although this is not the current recommendation of
pediatric or governmental organizations. Higher doses may be required if fat malabsorption,
obesity, or other causes exist that would enhance vitamin D catabolism and its destruction (10,
45; Figure 2).
As many as 4 different enzymes have been suggested to be capable of converting vitamin D to
25(OH)D (92). These enzymes most likely have different Km values for vitamin D and have
different levels of negative feedback regulation by the serum 25(OH)D concentration. Thus,
circulating 25(OH)D concentrations in response to vitamin D may be influenced by the baseline
25(OH)D concentration. As can be seen in Figure 5, the baseline concentration of 25(OH)D is
an important factor for how a person responds to a vitamin D dose. When serum 25(OH)D
concentrations were <50 nmol/L (20 ng/mL) in nursing home patients, doses of 200, 400, and
600 IU vitamin D2/d for 5 mo (23) raised serum 25(OH)D concentrations by 100% to 62
nmol/L (24 ng/mL). Only when the dose was increased to 800 IU/d for 5 mo did concentrations
rise above 75 nmol/L, or 30 ng/mL (Figure 5). However, subjects who had starting mean
25(OH)D concentrations above 64 nmol/L (25 ng/mL) showed no significant change in their
serum 25(OH)D concentrations when they took 200, 400, 600, or 800 IU/d. When the baseline
25(OH)D concentration was above 50 nmol/L (20 ng/mL), only 800 IU vitamin D2/d for 5 mo
was effective in raising the serum 25(OH)D level (Figure 5). This study evaluated vitamin D2,
which has been reported to be only 30% to 50% as effective as vitamin D3 in maintaining serum
25(OH)D concentrations (93, 94). Our data suggest that vitamin D2 was effective in raising blood
concentrations of 25(OH)D by 1 ng/100 IU, as has been reported for vitamin D3 (91, 95). These
data are consistent with our recent observation that 1000 IU vitamin D2/d was as effective as
1000 IU vitamin D3/d in raising and maintaining serum 25(OH)D concentrations (91). Thus,
physiologic doses of vitamin D2 may be equally effective as vitamin D3 in maintaining serum
25(OH)D concentrations.

View larger version:

In this page

In a new window

Download as PowerPoint Slide

FIGURE 5.
Mean (SE) circulating concentrations (A) and changes (B) in 25-hydroxyvitamin D [25(OH)D]
in nursing home residents with initial 25(OH)D serum concentrations of either <20 ng/mL ( )
or 20 ng/mL ( ) before and after receiving 0, 200, 400, 600, or 800 IU vitamin D2/d for 5
mo from October through March. Data are from 616 individuals. *P < 0.05; **P < 0.01; ***P <
0.001.
To treat vitamin D deficiency in the United States, 50 000 IU vitamin D2 (or vitamin D3, which is
available in Canada, Europe, Japan, and India) once a week for 8 wk often attains a 25(OH)D
concentration of 75 nmol/L (13). To maintain vitamin D sufficiency, Holick (10) recommends
that 50 000 IU vitamin D2 every 2 wk or its equivalent will sustain 25(OH)D concentrations
above 75 nmol/L.
Previous SectionNext Section

CONCLUSION
Throughout evolution, humans have depended on the sun for their vitamin D requirement (1, 2).
Indeed, a likely reason that melanin pigmentation devolved was to permit humans who migrated
north and south of the equator to make enough vitamin D in their skin to satisfy their
requirement (96). The recommendation for the avoidance of all sun exposure has put the world's
population at risk of vitamin D deficiency (97). This has become apparent in Australia, where a
dramatic increase in skin cancer rates resulted in the promotion of never exposing the skin to
direct sunlight without sun protection, ie, clothing or sunscreen. The so-called sun-safe message
has resulted in a marked increase in the risk of vitamin deficiency in Australia (40).

The best method for determining a person's vitamin D status is to measure a 25(OH)D
concentration. Most commercial assays are reliable enough to determine a person's vitamin D
status (10). These include various radioimmunoassays (98) and what is now considered to be the
gold standard: liquid chromatographytandem mass spectroscopy (14). There has been much
discussion about vitamin D2 being only 3050% as effective as vitamin D3 in maintaining
serum concentrations of 25(OH)D (93, 94). This, however, did not mean that vitamin D2 was less
active than vitamin D3 once it was metabolized to 1,25(OH)2D2. It only meant that vitamin D2
may need to be given in higher doses to raise the blood concentrations of 25(OH)D above 75
nmol/L, or 30 ng/mL. Our data (Figure 5), as well as our recent observation that vitamin D2
was as effective as vitamin D3 in raising the blood concentrations of 25(OH)D (91), however,
calls into question whether this is really necessary.
A reevaluation needs to take place of what the adequate intakes of vitamin D should be for
children and adults. The literature over the past decade suggests that the Institute of Medicine
recommendations in 1997 (83) are inadequate, and some experts including us suggest that both
children and adults should take 8001000 IU vitamin D/d from dietary and supplemental
sources (4, 9, 77) when sunlight is unable to provide it. This recommendation, however, has not
yet been embraced either by official government or pediatric organizations in the United States,
Canada, or Europe for either children or adults.
Previous SectionNext Section

Acknowledgments
Neither of the authors had a conflict of interest.
Previous SectionNext Section

Footnotes

2 Presented at the symposium Assessment of Vitamin D in Population-Based Studies,


held at Experimental Biology 2007 in Washington, DC, 1 May 2007.

3 Supported in part by NIH grant M01RR00533 and by the UV Foundation.

4 Reprints not available. Address corrrespondence to MF Holick, Boston University


School of Medicine, 715 Albany Street, M-1013, Boston, MA 02118. E-mail:
mfholick@bu.edu.

Previous Section

REFERENCES

1.
Holick MF. Phylogenetic and evolutionary aspects of vitamin D from phytoplankton to
humans. In: Pang PKT, Schreibman MP, eds. Vertebrate endocrinology: fundamentals
and biomedical implications. Vol 3. Orlando, FL: Academic Press, Inc (Harcourt Brace
Jovanovich), 1989:743.
2.
Holick MF. Vitamin D: A millennium perspective. J Cell Biochem 2003;88:296307.
CrossRefMedline
3.
Sniadecki J. Jerdrzej Sniadecki (17681838) on the cure of rickets. (1840) Cited by W
Mozolowski. Nature 1939;143:1214.
4.
Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest
2006;116:206272.
CrossRefMedline
5.
Hess AF. Collected writings, volume I. Springfield, IL: Charles C Thomas, 1936:669
719.
6.
Hess AF, Unger LJ. The cure of infantile rickets by sunlight. JAMA 1921;77:39.
CrossRef
7.
A British Paediatric Association Report. Infantile hypercalcaemia, nutritional rickets,
and infantile scurvy in Great Britain. Br Med J 1964;1:165961.
FREE Full Text
8.

Brot C, Vestergaard P, Kolthoff N, Gram J, Hermann AP, Sorensen OH. Vitamin D status
and its adequacy in healthy Danish perimenopausal women: relationships to dietary
intake, sun exposure and serum parathyroid hormone. Br J Nutr 2001;86:S97103.
CrossRefMedline
9.
Chen TC, Chimeh F, Lu Z, et al. Factors that influence the cutaneous synthesis and
dietary sources of vitamin D. Arch Biochem Biophys 2007;460:2137.
CrossRefMedline
10.
Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:26681.
CrossRefMedline
11.
Chapuy MC, Schott AM, Garnero P, Hans D, Delmas PD, Meunier J. Healthy elderly
French women living at home have secondary hyperparathyroidism and high bone
turnover in winter. J Clin Endocrinol Metab 1996;81:112933.
CrossRefMedline
12. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of
optimal vitamin D status. Osteoporos Int 2005;16:7136 (editiorial).
CrossRefMedline
13.
Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet
1998;351:8056.
Medline
14.
Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among
postmenopausal North American women receiving osteoporosis therapy. J Clin
Endocrinol Metab 2005;90:321524.
CrossRefMedline

15.
Thomas KK, Lloyd-Jones DH, Thadhani RI, et al. Hypovitaminosis D in medical
inpatients. N Engl J Med 1998;338:77783.
CrossRefMedline
16.
Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the
reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003;22:1426.
CrossRefMedline
17.
Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am
J Clin Nutr 1999;69:84256.
Abstract/FREE Full Text
18.
Huldschinsky K. Heilung von Rachitis durch Kunstliche Hohensonne. (Ultraviolet
irradiation of rachitic children.) Deutsche Med Wochenschr 1919;45:7123(in German).
CrossRef
19.
Bakhtiyarova S, Lesnyak O, Kyznesova N, Blankenstein MA, Lips P. Vitamin D status
among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia.
Osteoporos Int 2006;17:4416.
CrossRefMedline
20.
Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents
osteoporotic fractures in elderly community dwelling residents: a pragmatic populationbased 3-year intervention study. J Bone Miner Res 2004;19:3708.
CrossRefMedline
21.

Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25-dihydroxyvitamin D3


receptors and activities in muscle. J Biol Chem 1985;260:888291.
Abstract/FREE Full Text
22.
Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D
concentrations are associated with better lower-extremity function in both active and
inactive persons aged 60 y. Am J Clin Nutr 2004;80:7528.
Abstract/FREE Full Text
23.
Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel D. A higher dose
of vitamin D reduces the risk of falls in nursing home residents: a randomized, multipledose study. J Am Geriatr Soc 2007;55:2349.
CrossRefMedline
24.
Visser M, Deeg DJH, Lips P. Low vitamin D and high parathyroid hormone levels as
determinants of loss of muscle strength an muscle mass (sarcopenia): the longitudinal
aging study Amsterdam. J Clin Endocrinol Metab 2003;88:576672.
CrossRefMedline
25.
Malabanan AO, Turner AK, Holick MF. Severe generalized bone pain and osteoporosis
in a premenopausal black female: effect of vitamin D replacement. J Clin Densitom
1998;1:201204.
CrossRef
26. Aaron JE, Gallagher JC, Anderson J, et al. Frequency of osteomalacia and osteoporosis
in fractures of the proximal femur. Lancet 1974;1:22933.
Medline
27.
Al-Ali H, Fuleihan GEH. Nutritional osteomalacia: substantial clinical improvement and
gain in bone density post therapy. J Clin Densitom 2000;3:97101.

CrossRefMedline
28.
Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with
persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003;78:146370.
CrossRefMedline
29.
Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the
capacity of skin to synthesise vitamin D3. Lancet 1982;7476.
30.
Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF. Sunscreens suppress
cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987;64:11658.
CrossRefMedline
31.
Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous
synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not
promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988;67:3738.
CrossRefMedline
32.
Thacher TD, Fischer PR, Strand MA, Pettifor JM. Nutritional rickets around the world:
causes and future directions. Ann Trop Paediatr 2006;26:116.
CrossRefMedline
33.
Sedrani SH. Low 25-hydroxyvitamin D and normal serum calcium concentrations in
Saudi Arabia: Riyadh region. Ann Nutr Metab 1984;28:1815.
CrossRefMedline
34.

Fuleihan GEH, Nabulsi M, Choucair M, et al. Hypovitaminosis D in healthy


schoolchildrren. Pediatrics 2001;107:539.
35. Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among freeliving healthy young adults. Am J Med 2002;112:65962.
CrossRefMedline
36. Gordon CM, DePeter KC, Estherann G, Emans SJ. Prevalence of vitamin D deficiency
among healthy adolescents. Arch Pediatr Adolesc Med 2004;158:5317.
CrossRefMedline
37. Sullivan SS, Rosen CJ, Halteman WA, Chen TC, Holick MF. Adolescent girls in Maine at
risk for vitamin D insufficiency. J Am Diet Assoc 2005;105:9714.
CrossRefMedline
38. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid
function in postmenopausal women with osteoporosis: baseline data from the multiple
outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001;86:1212
21.
CrossRefMedline
39. Marwaha RK, Tandon N, Reddy D, et al. Vitamin D and bone mineral density status of
healthy schoolchildren in northern India. Am J Clin Nutr 2005;82:47782.
Abstract/FREE Full Text
40.
McGrath JJ, Kimlin MG, Saha S, Eyles DW, Parisi AV. Vitamin D insufficiency in southeast Queensland. Med J Aust 2001;174:1501.
Medline
41. Sato Y, Iwamoto J, Kanoko T, Satoh K. Amelioration of osteoporosis and hypovitaminosis
d by sunlight exposure in hospitalized, elderly women with Alzheimer's disease: a
randomized controlled trial. J Bone Miner Res 2005;20:132733.
CrossRefMedline
42.

Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC.
Hypovitaminosis D prevalence and determinants among African American and white
women of reproductive age: third National Health and Nutrition Examination Survey,
19881994. Am J Clin Nutr 2002;76:18792.
Abstract/FREE Full Text
43.
Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet
1989;2(8671):11045.
44.
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of
vitamin D in obesity. Am J Clin Nutr 2000;72:6903.
Abstract/FREE Full Text
45.
Zhou C, Assem M, Tay JC, et al. Steroid and xenobiotic receptor and vitamin D receptor
crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest
2006;116:170312.
CrossRefMedline
46.
Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer
Res 1941;1:1915.
FREE Full Text
47.
Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989;2:1176
8.
Medline
48. Gorham ED, Garland CF, Garland FC, et al. Vitamin D and prevention of colorectal
cancer. J Steroid Biochem Mol Biol 2005;97:17994.
CrossRefMedline

49. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Cancer
1992;70:28619.
CrossRefMedline
50.
Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses
of solar ultraviolet-B radiation. Cancer 2002;94:186775.
CrossRefMedline
51. Grant WG, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk
of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted
cancer mortality rates. Anticancer Res 2006;26:2687700.
Abstract/FREE Full Text
52.
Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status
and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:4519.
Abstract/FREE Full Text
53.
Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention.
Am J Public Health 2006;96:25261.
CrossRefMedline
54.
Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and
prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control
2000;11:84752.
CrossRefMedline
55.
Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Oglesby P. Dietary
vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men.
Lancet 1985;9:3079.

56.
Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and
calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin
Nutr 2007;85:158691.
Abstract/FREE Full Text
57.
Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy
associated with lower risk of type I diabetes on the offspring. Diabetologia
2000;43:10938.
CrossRefMedline
58.
Ponsonby A-L, McMichael A, van der Mei I. Ultraviolet radiation and autoimmune
disease: insights from epidemiological research. Toxicology 2002;181182:718.
59.
Embry AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadoliniumenhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol
2000;48:2712.
CrossRefMedline
60.
Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure
differences. Hypertension 1979;30:1506.
61.
Hypponen E, Laara E, Jarvelin M-R, Virtanen SM. Intake of vitamin D and risk of type 1
diabetes: a birth-cohort study. Lancet 2001;358:15003.
CrossRefMedline
62.
Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple
sclerosis. Neurology 2004;62:605.

Abstract/FREE Full Text


63.
Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is
inversely associated with rheumatoid arthritis. Arthritis Rheum 2004;50:727.
CrossRefMedline
64.
Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. Ultraviolet B and blood
pressure. Lancet 1998;352(9129):70910.
65.
McGrath J, Selten JP, Chant D. Long-term trends in sunshine duration and its
association with schizophrenia birth rates and age at first registrationdata from
Australia and the Netherlands. Schizophr Res 2002;54:199212.
CrossRefMedline
66.
Gloth FM III, Alam W, Hollis B. Vitamin D vs. broad spectrum phototherapy in the
treatment of seasonal effective disorder. J Nutr Health Aging 1999;3:57.
Medline
67.
Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal
vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab
2007;92:351722.
CrossRefMedline
68.
Chan TYK. Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int
2000;66:4768.
CrossRefMedline
69.

Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated


human antimicrobial response. Science 2006;3:17703.
70.
Holick MF, Garabedian M. Vitamin D: photobiology, metabolism, mechanism of action,
and clinical applications. In: Favus MJ, ed. Primer on the metabolic bone diseases and
disorders of mineral metabolism, 6th ed. Washington, DC: American Society for Bone
and Mineral Research, 2006:12937.
71.
DeLuca H. Overview of general physiologic features and functions of vitamin D. Am J
Clin Nutr 2004;80(suppl):1689S96S.
Abstract/FREE Full Text
72.
Bikle DD. Vitamin D: role in skin and hair. In: Feldman D, ed. Vitamin D. Burlington,
MA: Elsevier Academic Press, 2005:60930.
73. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S. 25-Hydroxyvitamin D31-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is
elevated during early cancerogenesis. Steroids 2001;66:28792.
CrossRefMedline
74. Tangpricha V, Flanagan JN, Whitlatch LW, et al. 25-Hydroxyvitamin D-1-hydroxylase
in normal and malignant colon tissue. Lancet 2001;357:16734.
CrossRefMedline
75. Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holiick MF. Human prostate cells
synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol
Biomarkers Prev 1998;7:3915.
Abstract/FREE Full Text
76.
Mawer EB, Hayes ME, Heys SE, et al. Constitutive synthesis of 1,25-dihydroxyvitamin D3
by a human small cell lung cell line. J Clin Endocrinol Metab 1994;79:55460.
CrossRefMedline

77.
Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands.
Endocr Rev 2005;26:66287.
CrossRefMedline
78.
Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1,25-dihydroxyvitamin
D3 inhibits angiogenesis in vitro and in vivo. Circ Res 2000;87:21420.
Abstract/FREE Full Text
79.
Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem
2003;88:32731.
CrossRefMedline
80.
Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D3 analogs as
immunomodulatory agents. Trends Mol Med 2002;8:1749.
CrossRefMedline
81. Adorini L. 1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation.
Curr Opin Investig Drugs 2002;3:145863.
Medline
82.
Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3,
and the immune system. Am J Clin Nutr 2004;80(suppl):1717S20S.
Abstract/FREE Full Text
83.
Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and
Nutrition Board, Institute of Medicine. Dietary reference intakes for calcium,
phosphorus, magnesium, vitamin D and fluoride. Washington, DC: National Academy
Press, 1999.

84.
National Osteoporosis Foundation. Statement on calcium and vitamin D. Internet:
http://www.nof.org/prevention/calcium/htm (accessed 16 November 2007).
85.
Cheng S, Tylavsky F, Kroger H, et al. Association of low 25-hydroxyvitamin D
concentrations with elevated parathyroid hormone concentrations and low cortical bone
density in early pubertal and prepubertal Finnish girls. Am J Clin Nutr 2003;78:48592.
Abstract/FREE Full Text
86.
Outila TA, Karkkainen MU, Lamberg-Allardt CJ. Vitamin D status affects serum
parathyroid hormone concentrations during winter in female adolescents: associations
with forearm bone mineral density. Am J Clin Nutr 2001;74:20610.
Abstract/FREE Full Text
87.
Guillemant J, Cabrol S, Allemandou A, Peres G, Guillemant S. Vitamin D-dependent
seasonal variation of PTH in growing male adolescents. Bone 1995;17:5136.
Medline
88.
Lehtonen-Veromaa M, Mottonen T, Nuotio I, Irjala K, Viikari J. The effect of
conventional vitamin D2 supplementation on serum 25(OH)D concentration is weak
among peripubertal Finnish girls: a 3-yr prospective study. Eur J Clin Nutr
2002;56:4317.
CrossRefMedline
89. Tangpricha V, Koutkia P, Rieke SM, Chen TC, Perez AA, Holick MF. Fortification of
orange juice with vitamin D: a novel approach to enhance vitamin D nutritional health.
Am J Clin Nutr 2003;77:147883.
Abstract/FREE Full Text
90. Vieth R, Garland C, Heaney R, et al. The urgent need to reconsider recommendations for
vitamin D nutrition intake. Am J Clin Nutr 2007;85:64950.

FREE Full Text


91.
Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in
maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab
2007 Dec 18 [Epub ahead of print].
92.
Jones G. Expanding role for vitamin D in chronic kidney disease: importance of blood
25-OH-D levels and extra-renal 1-hydroxylase in the classical and nonclassical actions
of 1,25-dihydroxyvitamin D3. Semin Dial 2007;20:31624.
CrossRefMedline
93.
Tang HM, Cole DEC, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3
increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin
Nutr 1998;68:8548.
Abstract
94.
Armas LAG, Hollis B, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in
humans. J Clin Endocrinol Metab 2004;89:538791.
CrossRefMedline
95.
Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin
Nutr 2003;77:20410.
Abstract/FREE Full Text
96.
Loomis WF. Vitamin D, sunlight and natural selection. Science 1967;157:5014.
Abstract/FREE Full Text
97.

Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need an how
should you get it? J Am Acad Dermatol 2006;54:30117.
CrossRefMedline
98.
Binkley N, Krueger D, Cowgill CS et al. Assay variation confounds the diagnosis of
hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004;89:31527.
CrossRefMedline

CiteULike

Delicious

Digg

Facebook

Google+

Mendeley

Reddit

StumbleUpon

Twitter

What's this?

Articles citing this article

Stability-Indicating HPLC-UV Method for Vitamin D3 Determination in Solutions,


Nutritional Supplements and Pharmaceuticals J Chromatogr Sci 2016 0: bmw048v1bmw048
o Abstract
o Full Text
o Full Text (PDF)

Dietary calcium intake influences the relationship between serum 25-hydroxyvitamin D3


(25OHD) concentration and parathyroid hormone (PTH) concentration Arch. Dis. Child.
2016 101: 316-319
o Abstract
o Full Text
o Full Text (PDF)

Minimizing Matrix Effects for the Accurate Quantification of 25-Hydroxyvitamin D


Metabolites in Dried Blood Spots by LC-MS/MS Clin. Chem. 2016 62: 639-646
o Abstract
o Full Text
o Full Text (PDF)

Association of Vitamin D Levels With Outcome in Patients With Melanoma After


Adjustment For C-Reactive Protein JCO 2016 0: JCO.2015.64.1357v1-JCO641357
o Abstract
o Full Text
o Full Text (PDF)

Assessment of Vitamin D Status and Response to Vitamin D3 in Obese and Non-Obese


Iranian Children J Trop Pediatr 2016 0: fmv091v1-fmv091
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D Status in Chronic Kidney Disease - UVB Irradiation Is Superior to Oral


Supplementation Anticancer Res 2016 36: 1397-1401
o Abstract
o Full Text

o Full Text (PDF)

Relationship between vitamin D, IFN-{gamma}, and E2 levels in systemic lupus


erythematosus Lupus 2016 25: 282-288
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D status and associated metabolic risk factors among North Korean refugees in
South Korea: a cross-sectional study BMJ Open 2015 5: e009140
o Abstract
o Full Text
o Full Text (PDF)

Association Between Serum 25-Hydroxy Vitamin D Levels and Blood Pressure Among
Adolescents in Two Resource-Limited Settings in Peru Am J Hypertens 2015 28: 10171023
o Abstract
o Full Text
o Full Text (PDF)

A systematic review protocol examining the effect of vitamin D supplementation on


endothelial function BMJ Open 2015 5: e006835
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2:
relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior FASEB J.
2015 29: 2207-2222
o Abstract

o Full Text
o Full Text (PDF)

Vitamin D Profile in National Football League Players Am J Sports Med 2015 43: 12411245
o Abstract
o Full Text
o Full Text (PDF)

Immunological role of vitamin D at the maternal-fetal interface J Endocrinol 2015 224:


R107-R121
o Abstract
o Full Text
o Full Text (PDF)

Healthy Start vitamins--a missed opportunity: findings of a multimethod study BMJ


Open 2015 5: e006917
o Abstract
o Full Text
o Full Text (PDF)

Common variants in CYP2R1 and GC genes are both determinants of serum 25hydroxyvitamin D concentrations after UVB irradiation and after consumption of vitamin
D3-fortified bread and milk during winter in Denmark Am J Clin Nutr 2015 101: 218227
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D Status Following Bariatric Surgery: Implications and Recommendations Nutr


Clin Pract 2014 29: 751-758

o Abstract
o Full Text
o Full Text (PDF)

Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue
alters pubertal glandular development Am. J. Physiol. Endocrinol. Metab. 2014 307:
E674-E685
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D-deficient osteomalacia due to excessive self-restrictions for atopic dermatitis


BMJ Case Reports 2014 2014: bcr2014204558
o Abstract
o Full Text
o Full Text (PDF)

The 3 Epimer of 25-Hydroxycholecalciferol Is Present in the Circulation of the Majority


of Adults in a Nationally Representative Sample and Has Endogenous Origins J. Nutr.
2014 144: 1050-1057
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism FASEB J.
2014 28: 2398-2413
o Abstract
o Full Text
o Full Text (PDF)

Yogurt consumption and impact on health: focus on children and cardiometabolic risk
Am J Clin Nutr 2014 99: 1243S-1247S
o Abstract
o Full Text
o Full Text (PDF)

Relationship of Vitamin D, HIV, HIV Treatment, and Lipid Levels in the Women's
Interagency HIV Study of HIV-Infected and Uninfected Women in the United States
Journal of the International Association of Providers of AIDS Care (JIAPAC) 2014 13:
250-259
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D Inhibits COX-2 Expression and Inflammatory Response by Targeting


Thioesterase Superfamily Member 4 J Biol Chem 2014 289: 11681-11694
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D supplementation and strontium ranelate absorption in postmenopausal women


with low bone mass Eur J Endocrinol 2014 170: 469-475
o Abstract
o Full Text
o Full Text (PDF)

Early Childhood Investments Substantially Boost Adult Health Science 2014 343: 14781485
o Abstract
o Full Text

o Full Text (PDF)

A comparison of hip fracture incidence rates among elderly in Sweden by latitude and
sunlight exposure Scand J Public Health 2014 42: 201-206
o Abstract
o Full Text
o Full Text (PDF)

Prevalence of Vitamin D Deficiency in Patients With Foot and Ankle Injuries Foot &
Ankle International 2014 35: 8-13
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D3 Deficiency Results in Dysfunctions of Immunity with Severe Fatigue and


Depression in a Variety of Diseases In Vivo 2014 28: 133-145
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D Insufficiency in a Sunshine-Sufficient Area: Southern Ethiopia Food Nutr Bull


2013 34: 429-433
o Abstract
o Full Text (PDF)

Suboptimal effect of different vitamin D3 supplementations and doses adapted to baseline


serum 25(OH)D on achieved 25(OH)D levels in patients with a recent fracture: a
prospective observational study Eur J Endocrinol 2013 169: 597-604
o Abstract
o Full Text

o Full Text (PDF)

The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to


genetic factors, BMI, and baseline levels Eur J Endocrinol 2013 169: 559-567
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D Deficiency Induces Early Signs of Aging in Human Bone, Increasing the Risk
of Fracture Sci Transl Med 2013 5: 193ra88
o Abstract
o Full Text
o Full Text (PDF)

Plasma 25-hydroxyvitamin D associated with pulmonary function in Canadian adults


with excess adiposity Am J Clin Nutr 2013 98: 174-179
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D Receptor and Retinoid X Receptor {alpha} Status and Vitamin D Insufficiency
in Models of Murine Colitis Cancer Prev Res 2013 6: 585-593
o Abstract
o Full Text
o Full Text (PDF)

Seasonality of vitamin D status in older people in Southern Germany: implications for


assessment Age Ageing 2013 42: 404-408
o Abstract
o Full Text

o Full Text (PDF)

The Relationship Between Maternal and Fetal Vitamin D, Insulin Resistance, and Fetal
Growth Reproductive Sciences 2013 20: 536-541
o Abstract
o Full Text
o Full Text (PDF)

Hypocalcemia in the Critically Ill patient J Intensive Care Med 2013 28: 166-177
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D status of refugees arriving in Canada: Findings from the Calgary Refugee
Health Program cfp 2013 59: e188-e194
o Abstract
o Full Text
o Full Text (PDF)

Superiority of a High Loading Dose of Cholecalciferol to Correct Hypovitaminosis D in


Patients with Inflammatory/Autoimmune Rheumatic Diseases The Journal of
Rheumatology 2013 40: 166-172
o Abstract
o Full Text
o Full Text (PDF)

Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular diseases or


malignancies in renal transplantation? Nephrol Dial Transplant 2012 27: iv47-iv52
o Abstract
o Full Text

o Full Text (PDF)

Vitamin D Status of Exclusively Breastfed 4-Month-Old Infants Supplemented During


Different Seasons Pediatrics 2012 130: e921-e927
o Abstract
o Full Text
o Full Text (PDF)

Maternal Early-Pregnancy Vitamin D Status Is Associated With Maternal Depressive


Symptoms in the Amsterdam Born Children and Their Development Cohort Psychosom.
Med. 2012 74: 751-757
o Abstract
o Full Text
o Full Text (PDF)

Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease


patients with hypovitaminosis D Nephrol Dial Transplant 2012 27: 3523-3531
o Abstract
o Full Text
o Full Text (PDF)

Predictors of Serum Vitamin D Levels in African American and European American Men
in Chicago Am J Mens Health 2012 6: 420-426
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian schoolage children: a randomized, double-blind, placebo-controlled feasibility trial Am J Clin
Nutr 2012 96: 391-396
o Abstract

o Full Text
o Full Text (PDF)

Vitamin D metabolism, sex hormones, and male reproductive function Reproduction


2012 144: 135-152
o Abstract
o Full Text
o Full Text (PDF)

Narrow-band ultraviolet B exposure increases serum vitamin D levels in haemodialysis


patients Nephrol Dial Transplant 2012 27: 2435-2440
o Abstract
o Full Text
o Full Text (PDF)

Effects of seasonal vitamin D deficiency and respiratory acidosis on bone metabolism


markers in submarine crewmembers during prolonged patrols J. Appl. Physiol. 2012 112:
587-596
o Abstract
o Full Text
o Full Text (PDF)

Renal Phosphate Loss in Long-Term Kidney Transplantation CJASN 2012 7: 323-331


o Abstract
o Full Text
o Full Text (PDF)

The Scots' Paradox: Can Sun Exposure, or Lack of it, Explain Major Paradoxes in
Epidemiology? Anticancer Res 2012 32: 237-248
o Abstract

o Full Text
o Full Text (PDF)

Vitamin D and Breast Cancer The Oncologist 2012 17: 36-45


o Abstract
o Full Text
o Full Text (PDF)

25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to
dietary sodium intake in Caucasians Journal of Renin-Angiotensin-Aldosterone System
2011 12: 311-319
o Abstract
o Full Text (PDF)

Randomized trial of fortified milk and supplements to raise 25-hydroxyvitamin D


concentrations in schoolchildren in Mongolia1,2 Am J Clin Nutr 2011 94: 578-584
o Abstract
o Full Text
o Full Text (PDF)

Why bother to take vitamins? J R Soc Med 2011 104: S19-S29


o Full Text
o Full Text (PDF)

Vitamin D is positively associated with sperm motility and increases intracellular calcium
in human spermatozoa Hum Reprod 2011 26: 1307-1317
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D and Chronic Lung Disease: A Review of Molecular Mechanisms and Clinical
Studies Adv Nutr 2011 2: 244-253
o Abstract
o Full Text
o Full Text (PDF)

The relation between acute changes in the systemic inflammatory response and plasma
25-hydroxyvitamin D concentrations after elective knee arthroplasty Am J Clin Nutr 2011
93: 1006-1011
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D and Diabetes Diabetes Spectr. 2011 24: 113-118


o Full Text
o Full Text (PDF)

Ultraviolet Exposure and Mortality among Women in Sweden Cancer Epidemiol.


Biomarkers Prev. 2011 20: 683-690
o Abstract
o Full Text
o Full Text (PDF)

Prevention and treatment of vitamin D deficiency in Dutch psychogeriatric nursing home


residents by weekly half-body UVB exposure after showering: a pilot study Age Ageing
2011 40: 211-214
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D and the Prevention of Hypertension and Cardiovascular Diseases: A Review of


the Current Evidence Am J Hypertens 2011 24: 253-262
o Abstract
o Full Text
o Full Text (PDF)

Prevention and Schizophrenia--The Role of Dietary Factors Schizophr Bull 2011 37: 272283
o Abstract
o Full Text
o Full Text (PDF)

Nutrition Concerns and Health Effects of Vegetarian Diets Nutr Clin Pract 2010 25: 613620
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D3 Suppresses Immune Reactions in Atherosclerosis, Affecting Regulatory T


Cells and Dendritic Cell Function Arterioscler. Thromb. Vasc. Bio. 2010 30: 2317-2319
o Full Text
o Full Text (PDF)

A Treatment Trial of Vitamin D Supplementation in Breast-fed Infants: Universal


Supplementation Is Not Necessary for Rickets Prevention in Southern Louisiana CLIN
PEDIATR 2010 49: 1053-1060
o Abstract
o Full Text (PDF)

Developmental Vitamin D Deficiency and Risk of Schizophrenia: A 10-Year Update


Schizophr Bull 2010 36: 1073-1078

o Abstract
o Full Text
o Full Text (PDF)

Blood 25-Hydroxyvitamin D3 Concentrations and Incident Sporadic Colorectal Adenoma


Risk: A Pooled Case-Control Study Am J Epidemiol 2010 172: 489-500
o Abstract
o Full Text
o Full Text (PDF)

A Moroccan woman with severe electrolyte disorder BMJ Case Reports 2010 2010:
bcr0820092188
o Abstract
o Full Text
o Full Text (PDF)

Maternal Vitamin D Deficiency Leads to Cardiac Hypertrophy in Rat Offspring


Reproductive Sciences 2010 17: 168-176
o Abstract
o Full Text (PDF)

Cod Liver Oil, the Ratio of Vitamins A and D, Frequent Respiratory Tract Infections, and
Vitamin D Deficiency in Young Children in the United States Ann Otol Rhinol Laryngol
2010 119: 64-70
o Full Text (PDF)

Breastfeeding Does Not Protect Against Urinary Tract Infection in the First 3 Months of
Life, but Vitamin D Supplementation Increases the Risk by 76% CLIN PEDIATR 2009
48: 750-755
o Abstract
o Full Text (PDF)

A Strategy for Analyzing Gene--Nutrient Interactions in Type 2 Diabetes J Diabetes Sci


Technol 2009 3: 710-721
o Abstract
o Full Text (PDF)

Serum 25-hydroxyvitamin D status of vegetarians, partial vegetarians, and


nonvegetarians: the Adventist Health Study-2 Am J Clin Nutr 2009 89: 1686S-1692S
o Abstract
o Full Text
o Full Text (PDF)

Epidemiologic Considerations in Unexplained Pediatric Arthralgia: The Role of Season,


School, and Stress The Journal of Rheumatology 2009 36: 427-433
o Abstract
o Full Text
o Full Text (PDF)

Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in


humans Carcinogenesis 2009 30: 101-105
o Abstract
o Full Text
o Full Text (PDF)

Treatment of Secondary Hyperparathyroidism in CKD Patients with Cinacalcet and/or


Vitamin D Derivatives CJASN 2009 4: 234-241
o Abstract
o Full Text
o Full Text (PDF)

Vitamin D and Hypertension: Does the Women's Health Initiative Solve the Question?
Hypertension 2008 52: 803-804
o Full Text
o Full Text (PDF)

Preface Am J Clin Nutr 2008 87: 1079S


o Full Text
o Full Text (PDF)

Previous | Next Article Table of Contents

This Article
1. Am J Clin Nutr April 2008
vol. 87 no. 4 1080S-1086S
1. AbstractFree
2. Full TextFree
3. Full Text (PDF)Free
1. Rent or Purchase Article
- Classifications
1.
o Supplement: Assessment of Vitamin D in Population-Based Studies
- Services
1. Email this article to a colleague
2. Alert me when this article is cited
3. Alert me if a correction is posted
4. Article Usage Statistics
5. Similar articles in this journal

6. Similar articles in PubMed


7. Download to citation manager
8. Purchase a print copy of this issue
9. Reprints and Permissions
+ Citing Articles
+ Google Scholar
+ PubMed
+ Agricola
- Social Bookmarking
1.
o
o
o
o
o

o
o
o
o
What's this?

Navigate This Article


1. Top
2. Abstract

3. HISTORICAL PERSPECTIVE
4. SOURCES OF VITAMIN D
5. CONSEQUENCES OF VITAMIN D DEFICIENCY ON THE MUSCULOSKELETAL
SYSTEM
6. CAUSES OF VITAMIN D DEFICIENCY
7. NONSKELETAL CONSEQUENCES OF VITAMIN D DEFICIENCY
8. MECHANISMS OF ACTION OF VITAMIN D
9. PREVENTION AND TREATMENT OF VITAMIN D DEFICIENCY
10. CONCLUSION
11. Acknowledgments
12. Footnotes
13. REFERENCES

This Article
1. Am J Clin Nutr April 2008
vol. 87 no. 4 1080S-1086S
1. AbstractFree
2. Full TextFree
3. Full Text (PDF)Free

Navigate This Article


1. Top
2. Abstract
3. HISTORICAL PERSPECTIVE
4. SOURCES OF VITAMIN D
5. CONSEQUENCES OF VITAMIN D DEFICIENCY ON THE MUSCULOSKELETAL
SYSTEM

6. CAUSES OF VITAMIN D DEFICIENCY


7. NONSKELETAL CONSEQUENCES OF VITAMIN D DEFICIENCY
8. MECHANISMS OF ACTION OF VITAMIN D
9. PREVENTION AND TREATMENT OF VITAMIN D DEFICIENCY
10. CONCLUSION
11. Acknowledgments
12. Footnotes
13. REFERENCES

Current Issue
1. April 2016, 103 (4)

1.
1. Alert me to new issues of Am J Clin Nutr

Statement of Scope

Information for Authors

Submit or Review a Manuscript

Editorial Board

Reprints

Permissions

Advertising

Feedback

Advances in Nutrition

The Journal of Nutrition

Nutrition Notes

The American Journal of Clinical Nutrition


Copyright 2016 by the American Society for Nutrition
9650 Rockville Pike, Bethesda, MD 20814

Print ISSN: 0002-9165

Online ISSN: 1938-3207

For an alternate route to AJCN Online use this URL: http://intl-ajcn.nutrition.org

Вам также может понравиться